Aurora Investment Counsel Takes Position in Addus HomeCare Corporation $ADUS

Aurora Investment Counsel acquired a new stake in Addus HomeCare Corporation (NASDAQ:ADUS) in the 1st quarter, Holdings Channel.com reports. The fund acquired 18,305 shares of the company’s stock, valued at approximately $1,714,000.

A number of other large investors have also recently added to or reduced their stakes in the company. Oregon Public Employees Retirement Fund boosted its position in Addus HomeCare by 2.5% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 4,153 shares of the company’s stock worth $446,000 after acquiring an additional 103 shares during the last quarter. ProShare Advisors LLC grew its position in Addus HomeCare by 3.1% in the fourth quarter. ProShare Advisors LLC now owns 3,527 shares of the company’s stock valued at $379,000 after purchasing an additional 105 shares in the last quarter. CANADA LIFE ASSURANCE Co grew its position in Addus HomeCare by 0.6% in the second quarter. CANADA LIFE ASSURANCE Co now owns 18,684 shares of the company’s stock valued at $2,150,000 after purchasing an additional 106 shares in the last quarter. State of Wyoming increased its stake in Addus HomeCare by 25.7% in the 4th quarter. State of Wyoming now owns 523 shares of the company’s stock valued at $56,000 after buying an additional 107 shares during the last quarter. Finally, Private Trust Co. NA increased its stake in Addus HomeCare by 65.5% in the 4th quarter. Private Trust Co. NA now owns 283 shares of the company’s stock valued at $30,000 after buying an additional 112 shares during the last quarter. Institutional investors own 95.35% of the company’s stock.

Insiders Place Their Bets

In other Addus HomeCare news, insider Heather Brianne Dixon sold 288 shares of the stock in a transaction on Monday, June 22nd. The stock was sold at an average price of $93.77, for a total transaction of $27,005.76. Following the transaction, the insider owned 44,371 shares in the company, valued at $4,160,668.67. This trade represents a 0.64% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 966 shares of company stock worth $90,168. 4.10% of the stock is owned by company insiders.

Addus HomeCare Price Performance

Addus HomeCare stock opened at $114.52 on Friday. The company has a market capitalization of $2.14 billion, a price-to-earnings ratio of 21.17, a PEG ratio of 1.57 and a beta of 0.88. The company has a current ratio of 1.83, a quick ratio of 1.83 and a debt-to-equity ratio of 0.08. Addus HomeCare Corporation has a 12 month low of $87.95 and a 12 month high of $124.43. The stock’s 50 day moving average is $97.48 and its 200-day moving average is $101.10.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings results on Monday, May 4th. The company reported $1.62 earnings per share for the quarter, topping the consensus estimate of $1.52 by $0.10. The business had revenue of $363.50 million during the quarter, compared to analysts’ expectations of $366.41 million. Addus HomeCare had a return on equity of 9.80% and a net margin of 6.89%.The firm’s revenue for the quarter was up 7.7% compared to the same quarter last year. During the same period last year, the firm posted $1.42 EPS. Equities research analysts expect that Addus HomeCare Corporation will post 6.24 EPS for the current year.

Wall Street Analyst Weigh In

Several brokerages have commented on ADUS. Citizens Jmp reissued a “market outperform” rating and set a $142.00 price target on shares of Addus HomeCare in a research report on Monday, May 18th. Barclays raised their price objective on Addus HomeCare from $92.00 to $96.00 and gave the company an “underweight” rating in a report on Wednesday, July 8th. Weiss Ratings raised Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, July 9th. Finally, Wall Street Zen lowered Addus HomeCare from a “strong-buy” rating to a “buy” rating in a report on Saturday, March 21st. One investment analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $131.50.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.